- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 03-06-2026: Press Release
03-06-2026 | 11:01 am
03-06-2026 | 11:01 am
Lupin and Natco received US FDA approval for Eribulin Mesylate Injection. This opens access to a US market with estimated annual sales of USD 43.7 million, a positive development for their generic portfolio.
No comments yet. Be the first to comment!